Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001045798 | SCV001209671 | pathogenic | not provided | 2023-12-13 | criteria provided, single submitter | clinical testing | This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 345 of the RHO protein (p.Val345Met). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with autosomal dominant retinitis pigmentosa (adRP) (PMID: 1808803, 1833777, 17488458, 28076437). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 13056). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt RHO protein function with a positive predictive value of 95%. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on RHO function (PMID: 8253795, 9724753). This variant disrupts the p.Val345 amino acid residue in RHO. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 24938718). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |
Centre for Genomic Medicine, |
RCV000013931 | SCV001443258 | likely pathogenic | Retinitis pigmentosa 4 | 2020-09-01 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV004814897 | SCV005070205 | pathogenic | Retinal dystrophy | 2022-01-01 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000013931 | SCV000034178 | pathogenic | Retinitis pigmentosa 4 | 2001-08-01 | no assertion criteria provided | literature only |